rs145081708
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_000484.4(APP):c.592T>C(p.Ser198Pro) variant causes a missense change. The variant allele was found at a frequency of 0.000319 in 1,614,066 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000484.4 missense
Scores
Clinical Significance
Conservation
Publications
- Alzheimer disease type 1Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- cerebral amyloid angiopathy, APP-relatedInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- ABeta amyloidosis, Arctic typeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- ABeta amyloidosis, dutch typeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- ABeta amyloidosis, Iowa typeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- ABeta amyloidosis, Italian typeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- ABetaA21G amyloidosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- ABetaL34V amyloidosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- early-onset autosomal dominant Alzheimer diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| APP | NM_000484.4 | c.592T>C | p.Ser198Pro | missense_variant | Exon 5 of 18 | ENST00000346798.8 | NP_000475.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000401 AC: 61AN: 152184Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000684 AC: 172AN: 251438 AF XY: 0.000640 show subpopulations
GnomAD4 exome AF: 0.000311 AC: 454AN: 1461882Hom.: 1 Cov.: 31 AF XY: 0.000311 AC XY: 226AN XY: 727246 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000401 AC: 61AN: 152184Hom.: 0 Cov.: 32 AF XY: 0.000350 AC XY: 26AN XY: 74350 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Alzheimer disease Benign:2
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
- -
not provided Uncertain:1
The S198P variant in the APP gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The S198P variant was not observed at any significant frequency in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The S198P variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret S198P as a variant of uncertain significance. -
not specified Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at